cardiac assist devices market research report

Cardiac Assist Devices Market - Global Outlook and Forecast 2020-2025

PUBLISHED DATE : Mar 2020 | Pages : 245

Up to $1650 off Untill Oct 2020

CARDIAC ASSIST DEVICES MARKET SIZE TO REACH USD 2.4 BILLION BY 2025, GROWING AT A CAGR OF 9% DURING THE FORECAST PERIOD

Cardiac Assist Devices Market Size, Share, & Trends Analysis Report by Application (Bridge To Transplant, Destination Therapy, and Others), Products (Intra-Aortic Balloon Pump, Ventricular Assist Devices, and Total Artificial Heart), End-Users (Hospitals and Special Cardiac Centers), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Global Analysis Report, Global Outlook, Market Trends, Competitive Landscape, Share, Growth Potential & Forecast, 2020-2025

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Customize this Report

Most Exhaustive Report

245 Pages

35 Tables

103 Charts

5 Regions

17 Countries

14 Companies

4 Market Segment

CARDIAC ASSIST DEVICES MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 2.4 BILLION (2025)
CAGR 9% (2020-2025)
Base Year 2019
Forecast Year 2020-2025
Market Segments Application (Bridge To Transplant, Destination Therapy, and Others), Products (Intra-Aortic Balloon Pump, Ventricular Assist Devices, and Total Artificial Heart), End-Users (Hospitals and Special Cardiac Centers)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, Germany, France, UK, Spain, Italy, Japan, China, Australia, South Korea, India, Brazil, Mexico, Argentina, Turkey, and Saudi Arabia

INDUSTRY INSIGHTS

The cardiac assist devices market size to reach USD 2.4 billion by 2025, growing at a CAGR of 9% during the forecast period. The cardiac assist devices market is expected to observe significant growth on account of the growing incidence of congestive heart failures worldwide, especially in the geriatric population. With increased awareness of heart failures among patients and the availability of advanced treatment options, the market is likely to witness growth during the forecast period.

The emergence of next-generation cardiac assist devices is expected to fuel industry growth during the forecast period. The industry has witnessed the launch of several advanced and innovative heart assist devices with major changes in product designs and material usage. The introduction of less invasive devices by surgeons to perform left ventricular assist devices (LVAD) implant surgeries efficiently is leading to promising post-surgical outcomes.

Moreover, the global cardiac assist devices market is likely to grow during the forecast period due to increasing technological advancements, new product approvals, increasing elderly population, improvements in reimbursement policies for heart failures, and associated comorbidities. Vendors are likely to focus on addressing unmet patient need as the demands for innovative cardiac assist devices is growing due to promising clinical outcomes, thereby increasing opportunities for vendors.

SNIPPETS

  • In the US, over 8 million people are expected to experience heart-related disorders by 2030, which is likely to boost the demand for cardiac assist devices.
  • The growth of the geriatric population in France, which is expected to reach 30% by 2050 from 25% in 2030, is likely to contribute to market growth.
  • In Spain, the high penetration of advanced cardiac assist devices is likely to influence the market positively.

CARDIAC ASSIST DEVICES MARKET SEGMENTATION

This research report includes detailed segmentation by

  • Application
  • Products
  • End-users
  • Geography

INSIGHTS BY APPLICATION 

The application of bridge to transplant (BTT) is enhancing the quality of life and survival chances of patients. The segment is expected to grow steadily due to advances in technology. The entry of advanced and innovative products from first-generation pulsatile flow cardiac assist devices to third-generation continuous flow devices is immensely influencing market growth prospects. However, the segment is likely to witness a decline during the forecast due to the increasing usage of cardiac assist devices as a destination therapy for treating advanced heart failure.

The destination therapy (DT) segment is expected to grow at the fastest CAGR on account of the shortage of heart donors, increasing prevalence of end-stage heart failures, and the availability of effective therapies to treat heart failures. The demand for DT is likely to increase as it supports long-term cardiac function in end-stage heart failure patients, who are ineligible for heart transplantation.

INSIGHTS BY PRODUCTS 

Left ventricular assist devices (LVAD) are predominantly used to bridge to transplant and destination therapy compared to other devices. The usage of LVAD has significantly improved the survival rate among patients undergoing heart transplantation. The application of LVADs in patients requiring cardiac support for longer duration enhances the quality of life and survival chances. These factors are likely to influence patients to prefer LVAD implants, thereby bolstering the demand for LVADs.

Intra-aortic balloon pumps (IABP) are considered to be the first line of treatment, especially in low and middle-income countries, and help treat the patient at critical stages. The segment is expected to grow due to several surgeons recommending IABP for treating advanced heart failures. IABPs provide safer use and earlier intervention to provide hemodynamic support and has minimal complications than other cardiac assist devices.

INSIGHTS BY END-USERS 

The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings. Patients prefer undergoing advanced heart failure treatment in hospitals due to their convenient locations and ease of accessibility. Moreover, the aging population and shortage of heart donors are other major factors likely to drive the segment growth.

Specialty cardiac centers (SSCs) are solely dedicated to treating patients suffering from several CVDs, such as vascular stenosis and heart failure. The segment is expected to grow at the fastest CAGR due to the availability of sophisticated infrastructure related to the diagnosis and high-quality treatment of CVDs in standalone cardiology centers.

INSIGHTS BY GEOGRAPHY

The North American market is expected to grow at the fastest CAGR due to favorable patient demographics, availability of skilled surgeons, and favorable reimbursement coverage. The increasing prevalence of obesity and diabetes, coupled with the aging population, has increased heart failures, which are expected to bolster the market. In Europe, the market is likely to grow because of the increasing geriatric population with heart diseases and high awareness of the advantages of cardiac assist devices. Further, increased government investments for such devices are likely to boost industry growth. Germany, the UK, and France are the key countries in the region as they invest the highest in R&D activities than other European countries. The APAC market is expected to grow at a moderate rate due to the increased healthcare expenditure, coupled with a high prevalence of CVDs. Favorable government policies and increased vendor initiatives in spreading awareness of stents are the other primary factors likely to influence the industry.

INSIGHTS BY VENDORS

The global cardiac assist devices market is highly consolidated with major players accounting for a significant share of the industry. However, there are considerable growth opportunities for new entrants. Several investigational and small med-tech companies are expected to offer innovative products and technologies. The leading players are focusing on implementing several strategies such as product launches and approvals, acquisitions, and an increase in R&D investment to enhance their market share. Moreover, they focus on expansion in existing and new industries to cater to the needs of growing customer base, widen their product portfolios, and boost their production capabilities to gain traction from end-users. Leading players are likely to dominate the industry on account of their strong presence and surgeons’ endorsement for their products due to the availability of abundant clinical data and efficacy.

The cardiac assist devices market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Application

  • Bridge to Transplant
  • Destination Therapy
  • Others

By Product

  • Intra-aortic Balloon Pump (IABP)
  • Ventricular Assist Devices (VADs)
  • Left Ventricular Assist Devices (LVADs)
  • Other VADs
  • Total Artificial Heart (TAH)

By End-user  

  • Hospitals
  • Special Cardiac Centers

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia

Frequently Asked Questions

The cardiac assist devices market size to reach revenues of $2.4 billion, growing at a CAGR of over 9% during 2019-2025.
The cardiac assist devices market is expected to observe significant growth on account of the growing incidence of congestive heart failures worldwide, especially in the geriatric population.
The leading players in the cardiac assist devices market include Abbott and Medtronic.
The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings.
Read More

Select a license type that suits your business needs

Single User Licence
$2345.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$2680.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$3350.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1005.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Select a license type that suits your business needs

Best Value Tag
Coming Soon
  • Stay tuned with us.

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

Our Clients

33%

Off

OFF

DAYS

HOURS

MINUTES

SECONDS

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date